会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHOD OF SCREENING REMEDY FOR HEART DISEASE AND MEDICINAL COMPOSITION FOR TREATING HEART DISEASE
    • 用于治疗心脏疾病的心脏疾病和药物组合物的筛选方法
    • WO2004091476A2
    • 2004-10-28
    • PCT/JP2004005382
    • 2004-04-15
    • ONO PHARMACEUTICAL COHONJO TASUKUOKAZAKI TAKU
    • HONJO TASUKUOKAZAKI TAKU
    • A61K20060101A61K38/17A61K45/00A61P9/00C12Q1/02G01N33/15G01N33/50G01N33/53G01N33/564A61K
    • G01N33/564A61K38/17G01N33/5061G01N2800/325
    • A method of screening a substance inhibiting the onset of a disease in which an anti-myocardial troponin I autoantibody participates; a medicinal composition for treating a heart disease and a base material for treating a heart disease containing a substance produced by the above method; an apparatus for treating a heart disease in which an anti-myocardial troponin I autoantibody participates whereby the above antibody is removed; a method of constructing an animal for evaluating a heart disease which comprises administering an anti-myocardial troponin I autoantibody; a method of selecting a remedy for a heart disease with the use of the above animal; and a method of diagnosing dilated cardiomyopathy which comprises quantifying an anti-myocardial troponin I autoantibody. The above-described treatment apparatus whereby the anti-myocardial troponin I autoantibody is removed and the medicinal composition for treating a disease in which the antibody participate are useful in treating and/or preventing a heart disease.
    • 一种筛选抑制其中抗心肌肌钙蛋白I自身抗体参与的疾病发作的物质的方法; 用于治疗心脏病的药物组合物和用于治疗含有通过上述方法生产的物质的心脏病的基础材料; 用于治疗心肌疾病的装置,其中抗心肌肌钙蛋白I自身抗体参与,从而除去上述抗体; 一种构建用于评估心脏病的动物的方法,其包括施用抗心肌肌钙蛋白I自身抗体; 使用上述动物选择心脏病的补救方法; 以及诊断扩张型心肌病的方法,其包括定量抗心肌肌钙蛋白I自身抗体。 除去抗心肌肌钙蛋白I自身抗体的上述治疗装置和用于治疗抗体参与的疾病的药物组合物可用于治疗和/或预防心脏病。
    • 2. 发明申请
    • POLYPEPTIDE PRODUCED BY STROMAL CELL
    • 由细胞产生的多肽
    • WO1996001843A1
    • 1996-01-25
    • PCT/JP1995001342
    • 1995-07-05
    • ONO PHARMACEUTICAL CO., LTD.HONJO, TasukuNAKANO, TohruHIRANO, AtsushiSIBAYAMA, ShiroOHNO, Hiroyuki
    • ONO PHARMACEUTICAL CO., LTD.
    • C07K14/435
    • C07K14/47A61K38/00
    • A polypeptide produced by mouse marrow stromal cells and composed of 211 amino acid residues, and a human homolog thereof; a process for producing the polypeptide; a DNA coding for the polypeptide; a fragment hybridizing selectively with the DNA sequence; a replication or expression vector comprising the DNA; a host cell transformed by the vector; an antibody against the polypeptide; and a pharmaceutical composition containing the polypeptide or the antibody. The polypeptide is usable for the prevention or treatment of the hypoplasia or abnormal growth of hematopoietic cells, the hyperergasia or hypergasia of the nervous system, diseases related to the hyperergasia or hypergasia of the immune system, such as inflammatory diseases, the decrease of hematopoietic cells after bone marrow transplantation, the decrease of leucocytes, platelets, B cells or T cells after radiation therapy, anemia and infectious diseases; the prevention or treatment of cancer, leukemia and AIDS; the prevention or treatment of various degenerative diseases and nerve injury; the prevention of treatment of metabolic disorder of the bone; and tissue repair.
    • 由小鼠骨髓基质细胞产生并由211个氨基酸残基组成的多肽及其人类同源物; 一种生产该多肽的方法; 编码该多肽的DNA; 与DNA序列选择性杂交的片段; 包含DNA的复制或表达载体; 由载体转化的宿主细胞; 抗多肽的抗体; 和含有多肽或抗体的药物组合物。 该多肽可用于预防或治疗造血细胞发育不全或异常生长,神经系统的高血压或高血压,与免疫系统的高血压或高血压有关的疾病,如炎性疾病,造血细胞减少 骨髓移植后,放射治疗后,白细胞,血小板,B细胞或T细胞减少,贫血和感染性疾病; 预防或治疗癌症,白血病和艾滋病; 预防或治疗各种退行性疾病和神经损伤; 预防骨代谢紊乱的治疗; 和组织修复。